Ambev S.A. (ABEV)
Last Price$2.40.4%
Market Cap$36.6B
ABEV Rating
ABEV Quality rating performance
ABEV Intrinsic Value
Key Highlights:
As of Mar 18, 2025 ABEV Relative Value is $2.5, which is undervalued by 7.7%, compared to current share price of $2.4.
As of Mar 18, 2025 ABEV DCF Value is $2.9, which is undervalued by 22.3%, compared to current share price of $2.4.
ABEV Share Price History
1W 7.3%
1M 23.0%
6M 3.5%
YTD (10.6%)
1Y (1.7%)
3Y (3.3%)
5Y 39.1%
10Y (40.7%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
ABEV Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$36.6B
$32.2B
R$89.5B
R$21.3B
Shares Outstanding
16B
Employees
N/A
Growth (CAGR)
11.2%
3.94%
12.4%
15.75%
Profitability
51.2%
24.4%
16.1%
29.2%
23.9%
145.8%
Intrinsic Value
$2.8 (17.2% undervalued)
$2.9
$2.6
84.0%
Return on Capital
Financial Health
(R$26.4B)
(1.2x)
Dividends
(8.6%)
1.9%
19.0%
Mar 18, 2025
Earnings
May 14, 2025
MISS by (414.1%)
MISS by 0.0%
(24.0%)
6 Beat & 4 Miss
ABEV Stock Financials
ABEV Income Statement Metrics
Annual
Quarterly
LTM
ABEV Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$4,816.0M +5.6% YoY
Capital Expenditure (CAPEX)
($876.3M) -20.9% YoY
Free Cash Flow (FCF)
$3,939.6M +14.1% YoY
ABEV Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$16.5B 12.2% YoY
Cost of revenue
$8,048.1M 11.0% YoY
Pre-tax income
$3,595.9M 29.6% YoY
21.8% margin
ABEV Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$26.2B
Current assets ($8,735.3M, 33.3% of total)
$4,812.8M (18.4%)
$1,011.3M (3.9%)
Other current assets
$2,911.2M (11.1%)
Non-current assets ($17.5B, 66.7% of total)
$93.5M (0.4%)
$4,866.5M (18.6%)
$2,021.2M (7.7%)
Other non-current assets
$10.5B (40.0%)
Financial position
($4,255.9M)
Cash & Short-term
Investments
Total Debt
ABEV Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
ABEV Earnings Surprises
Crunching data... Almost there!
ABEV Dividends
ABEV Dividend Yield
Crunching data... Almost there!
ABEV Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with ABEV
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$36.6B | 6.9 | $2.8 17.2% undervalued | (1.7%) | R$89.5B | R$21.3B | 11.8% | 23.9% | 51.2% | 21.7% | 3.5% | |
$178.5B | 4.7 | $30.6 69.2% overvalued | (19.6%) | MX$737.3B | MX$12.3B | (2.1%) | 1.7% | 41.5% | 10.0% | 67.3% | |
$127.7B | 6.6 | $74.4 17.1% undervalued | 6.9% | $74.8B | $10.4B | 26.0% | 13.8% | 55.3% | 18.8% | 79.5% | |
$23.0B | 5.8 | $72.5 52.0% undervalued | (18.1%) | $85.5B | $1,219.0M | (9.0%) | 1.4% | 6.8% | 7.7% | 45.3% | |
$12.7B | 5.5 | $46.6 111.4% undervalued | 8.6% | $79.9B | $907.8M | 1.0% | 1.1% | 27.8% | 8.0% | 422.2% | |
$12.1B | 5.8 | $54.2 8.0% overvalued | (9.9%) | $11.6B | $1,236.2M | (0.6%) | 10.6% | 38.4% | 9.2% | 46.0% | |
$2,771.3M | 5.2 | $35.1 132.7% undervalued | 28.9% | CLP 2,509.1B | CLP 108.0B | (9.1%) | 4.3% | 44.4% | 11.4% | 92.5% | |
$2,581.6M | 5.6 | $191.0 13.9% overvalued | (23.6%) | $2,039.9M | $172.6M | 1.6% | 8.5% | 43.8% | 5.8% | 3.9% | |
$1,637.6M | 7.0 | $19.3 7.1% undervalued | (17.0%) | R$3,185.2M | R$887.9M | 16.7% | 27.9% | 61.6% | 13.0% | 75.2% | |
$225.8M | 4.9 | $9.3 10.0% undervalued | (18.0%) | $305.5M | $23.8M | (19.4%) | 7.8% | 10.0% | (0.1%) | 680.6% | |
$13.9M | 4.7 | $4.8 441.8% undervalued | (43.1%) | CN¥250.8M | CN¥0.0 | 15.8% | 0.0% | 51.8% | (12.8%) | 59.9% |
FAQ
What is Ambev S.A. (ABEV) stock rating?
As of today, Ambev S.A. has a stock rating of 7 (out of 10), which is considered Good.
is Ambev S.A. (ABEV) a good stock to buy?
As of today, Ambev S.A. has a Good stock rating, which is 17.2% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.